Your browser doesn't support javascript.
loading
Anti-cancer drug discovery and development summit.
Blakey, David C.
Afiliação
  • Blakey DC; AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK. david.blakey@astrazeneca.com
Expert Opin Investig Drugs ; 12(9): 1577-82, 2003 Sep.
Article em En | MEDLINE | ID: mdl-12943502
ABSTRACT
The 5th Annual Anti-Cancer Drug Discovery and Development Summit brought together an international group of academic and industry scientists to discuss recent therapeutic developments in the field of oncology. The focus of the meeting was novel targeted approaches, i.e., those agents directed against targets that are overexpressed or overactive in tumour cells. It was acknowledged that cytotoxic agents will continue to play a key role in the treatment of cancer and new developments in this area were also discussed. With over 400 anticancer drugs in clinical development and a number of recent registrations, there is great optimism that significant therapeutic advances can be made.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Expert Opin Investig Drugs Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Expert Opin Investig Drugs Ano de publicação: 2003 Tipo de documento: Article